Abubuwan da za a bi don lura da nau'in ciwon sukari na type 2 mellitus (DM) suna canzawa kowace shekara. Wannan saboda ci gaban ilimin kimiyyar likita ne, ma'anar manyan abubuwan da ke haifar da ƙungiyoyi masu haɗari.
Zuwa yau, masana'antar samar da magunguna na iya bayar da azuzuwan 12 na magunguna daban-daban, wanda ya bambanta duka a cikin aikin aiwatarwa da farashin farashi.
Yawancin magunguna sau da yawa yana haifar da rikicewa a tsakanin marasa lafiya har ma da kwararrun likitoci. Wannan ba abin mamaki bane, saboda kowane masana'anta yana ƙoƙarin ba da abu mai aiki sabon suna na son rai.
A cikin wannan labarin zamu tattauna game da ciwon sukari, analogues da kwatantawa da wasu kwayoyi. Wannan magani ne wanda ya fi shahara tsakanin masana ilimin halayyar dabbobi. Wannan saboda yawanci saboda kyakkyawan darajar ingancin-ƙimar.
Ciwon sukari da masu ciwon sukari MV: bambance-bambance
Ciwon sukari - abu mai aiki na miyagun ƙwayoyi shine glyclazide, wanda ke nufin abubuwan samo asali na sulfonylurea. Fiye da shekaru 50 a kasuwa, ƙwayar ta nuna kyakkyawan bayanin martaba na aminci da ingancin asibiti.
Diabeton yana ƙarfafa aikin insulin ta hanyar sel beta na pancreas, yana haɓaka shigarwar glucose cikin kyallen, yana ƙarfafa bango na jijiyoyin jiki, kuma yana hana ci gaban nephropathy.
Allunan Diabeton MV 60 MG
A takaice dai yana shafar ayyukan coagulation na jini. Babban hasara na miyagun ƙwayoyi shine sakewarsa mara daidaituwa don haka tasiri na sawtooth yayin rana. Nau'in metabolism ɗin yana haifar da canji mai mahimmanci a cikin ƙwayar glycemia.
Masana kimiyya sun sami wata hanyar fita daga wannan halin kuma sun kirkiro Diabeton MV (sannu a hankali an sake su). Wannan magani ya bambanta da magabata a cikin santsi da kuma jinkirin sakin abu mai aiki - glyclazide. Don haka, glucose ana samun daidaituwa akan wani yanki.
Zan iya ɗauka a lokaci guda?
Tare da Maninil
Tsarin Maninyl ya haɗa da glibenclamide - abu mai aiki, wanda, kamar gliclazide, ya kasance ne daga cikin abubuwan da ke faruwa na sulfanylurea.
Nadin wakilai biyu na rukuni na kimiyyar magunguna iri ɗaya ba bu mai kyau ba.
Wannan saboda gaskiyar cewa haɗarin haɓaka sakamako masu illa suna ƙaruwa.
Tare da Glucophage
Abubuwan da ke aiki na Glucofage shine metformin, wakilin aji na biguanide. Tushen hanyar aiki shine karuwa a cikin haƙuri da karuwa a cikin adadin ƙin karuwar carbohydrates a cikin hanji.
Allunan glucofage 1000 mg
Dangane da shawarar da Associationungiyar ofungiyar Clinical Endocrinology (2013), an tsara metformin da farko don nau'in ciwon sukari na 2. Wannan abin da ake kira monotherapy, idan ba shi da tasiri, ana iya haɗa shi da wasu magunguna, ciki har da Diabeton. Don haka, amfani da waɗannan magunguna guda biyu abu ne mai karɓa kuma halal ne.
Wanne ne mafi kyau?
Glurenorm
Glyurenorm ya haɗa da glycidone, wakilin aji na sulfanylurea.
Dangane da inganci da aminci, wannan ƙwayar magani ta fi ta Diabeton ƙarfi, amma a lokaci guda ya fi tsada (kusan sau biyu).
Daga cikin fa'idodin, ingantaccen farawa na aiki, ƙaramar haɗarin hauhawar jini, da ingantaccen bioavailability ya kamata a haskaka. Ana iya ba da shawarar miyagun ƙwayoyi a matsayin ɓangare na hadaddun lura da ciwon sukari.
Amaril
Glimepiride (sunan kasuwanci Amaryl) shine asalin ƙarni na uku wanda ya samo asali na sulfonylurea, sabili da haka, magani ne na zamani.Yana ƙarfafa samar da insulin-insulin na tsawon lokaci (har zuwa 10 - 15 awanni).
Da kyau yana hana irin wannan rikicewar cututtukan cututtukan ƙwayar cuta kamar raunin gani da rashin ƙwayar cuta.
A kan tushen ɗaukar Amaril, haɗarin haɓakar haɓakar jini shine 2 - 3%, sabanin masu ciwon sukari (20 - 30%).Wannan shi ne saboda gaskiyar cewa glimeperide baya hana ɓoyewar glucagon a cikin martani ga raguwar matakan glucose jini. Magungunan yana da tsada mai tsada, wanda ke shafar kasancewarsa ta duniya.
Maninil
A farkon farfaɗo don sabbin cututtukan ƙwayar cutar sankara na mellitus, likitoci sun ba da shawarar gyaran salon rayuwa (asarar nauyi, ƙara yawan motsa jiki). Game da ƙarancin aiki, an haɗa magungunan ƙwaƙwalwar ƙwayar cuta ta Metformin.
Allunan Maninil 3.5 MG
An zabi kashi a cikin wata guda, ana kula da glycemia, metabolism na lipid, da excretion protein na koda. Idan, a kan asalin magani tare da Metformin, ba zai yiwu a sarrafa cutar ba, to, an sanya magani na wata ƙungiya (mafi yawan lokuta ana samo maganin sulfanilurea) - sau biyu.
Duk da gaskiyar cewa an kirkiro Maninil a farkon 60s, ya ci gaba da zama mashahuri kuma yana fafatawa da Diabeton. Wannan ya faru ne saboda karancin farashi da wadatar da ake samu. Zabi na miyagun ƙwayoyi yakamata a gudanar da aikin endocrinologist kan dalilin anamnesis da kuma karatun asibiti da kuma ɗakunan bincike.
Glibomet
Glibomet shine ɗayan magunguna masu haɓaka yawancin sukari. Ya ƙunshi 400 MG na metformin hydrochloride da 2.5 MG na glibenclamide.
Glibomet yafi tasiri fiye da ciwon sukari.
Saboda haka, a cikin nau'i na kwamfutar hannu guda ɗaya, mai haƙuri ya ɗauki abubuwa biyu masu aiki na rukuni daban-daban na magunguna lokaci guda.
Glucophage
Abubuwan da ke aiki da Glucofage shine metformin hydrochloride.
An wajabta shi ne don sabbin cututtukan cututtukan cututtukan ƙwayar cuta a cikin yanayin rage cin abinci. Yana da sakamako masu illa da yawa, alal misali, haɓakar lactic acidosis da hypoglycemia.
Saboda haka, Diabeton magani ne mai aminci, sabanin Glucofage, yana tayar da ruɗar insulin.
Gliclazide MV
Gliclazide tare da jinkirin sakin abu mai aiki cikin ladabi yana daidaita da matakin glycemia, yayin shan wannan magani babu kusan yanayin rashin jini.Saboda ƙirar sunadarai, ana iya ɗauka sau ɗaya a rana.
Bayan tsawan amfani, ba a lura da jaraba da raguwar aiki (ba a tsayar da aikin insulin ba).
An lura da kaddarorin antiaggregant na MV Glyclazide da sakamako na sakewa akan bango na jijiyoyin bugun gini. Ciwon sukari ya fi ƙarfin inganci, bayanin martaba, amma ya fi ƙima tsada.
Glidiab MV
Glidiab MV ya ƙunshi gliclazide, wanda a hankali aka sake shi. Idan aka kwatanta da Diabeton MV, za a iya tsara magungunan biyu a yanayin aikin asibiti guda ɗaya, suna da ƙananan sakamako masu illa da halayen da ba su dace ba.
Bidiyo masu alaƙa
Duk abin da kuke buƙatar sani game da Diabeton a cikin bidiyon:
Yana da mahimmanci a tuna cewa ciwon sukari hanya ce ta rayuwa. Idan mutum bai daina munanan halaye ba, bai kula da jikinsa ba, to ba magani daya zai taimaka masa ba. Don haka, masana kimiyya sun tabbatar da cewa nan da shekarar 2050 kowane mazauni na uku a duniya zai iya fama da wannan cuta.
Wannan ya faru ne sakamakon raguwar al'adun abinci, matsala mai haɓaka kiba. Gabaɗaya, ba cutar kansa ba ce mai muni, amma rikice-rikicen da ke haifar da shi. Daga cikin matsalolinda suka fi yawa sune rashin hangen nesa, gazawar koda, matsalar rashin jijiyoyin hannu da yaduwar kwakwalwa.
Lalacewa ga tasoshin da jijiyoyin ƙananan ƙarshen yana haifar da nakasa da wuri. Dukkanin rikice-rikicen da ke sama za a iya hana su tazara sosai idan an bi shawarar mahaɗin endocrinologist.
